Eva van Doorn

Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors

Petra J. Woestenberg, Audrey J. King, Birgit van Benthem et al. · The Journal of Infectious Diseases · 2017 · 84 citations · Full text

Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine

Eva van Doorn, Heng Liu, Tamar Ben-Yedidia et al. · Medicine · 2017 · 49 citations · Full text

Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial

Eva van Doorn, Olga Pleguezuelos, Heng Liu et al. · BMC Infectious Diseases · 2017 · 35 citations · Full text

Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes

Maryam Darvishian, Frederika Dijkstra, Eva van Doorn et al. · PLoS ONE · 2017 · 34 citations · Full text

No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors

Petra J. Woestenberg, Audrey J. King, Marianne A. B. van der Sande et al. · Journal of Infection · 2017 · 27 citations · Full text